|
|
||||||||
Ann Thorac Surg 2005;80:647-654
© 2005 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery, Pediatric Cardiology and Ahmanson, University of California, Los Angeles Adult Congenital Heart Disease Center, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California
Accepted for publication March 4, 2005.
* Address reprint requests to Dr Odim, Division of Cardiothoracic Surgery, David Geffen School of Medicine at UCLA, Room 62-266B, 10833 Le Conte Ave, Los Angeles, CA 90095-1741 (Email: jodim{at}mednet.ucla.edu).
Presented at the Fortieth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 2628, 2004.
| Abstract |
|---|
|
|
|---|
METHODS: Sixty-two patients underwent reparative aortic valve surgery from January 1997 through December 2003. The mean age was 25 ± 20 years (± standard deviation) (range, 10 days to 81 years). Fifty percent (31 of 62) were less than 19 years old at operation. The diagnoses included bicuspid aortic valve (39 patients), ventricular septal defect (14 patients), severe aortic stenosis (6 patients), subaortic stenosis (7 patients), bacterial endocarditis (7 patients), neonatal truncus arteriosus (2 patients), Shones complex (2 patients), transposition complex (1 patient), double-chambered right ventricle (1 patient), and Marfans syndrome (1 patient). Twelve patients (19 %) had prior sternotomy and cardiac operations. Valve-sparing techniques included pericardial leaflet extensions in 62 patients, creation of one or more pericardial neoaortic sinuses in 8, subcommissuroplasty in 8, pericardial patch of perforated leaflets in 9, Dacron mesh wrap (Boston Scientific, Wayne, NJ) of dilated ascending aorta in 12, and concomitant tricuspid and mitral valve repairs in 3 and 4 patients, respectively.
RESULTS: There was one early death (1.6%). There were no late deaths at a mean follow-up of 25 ± 16 (range, 0.1 to 72.5 months). Six patients required reoperation and prosthetic or homograft replacement for aortic valve incompetence. One out of 6 reoperations required re-repair. The remaining patients are well with a mean aortic regurgitation grade by echocardiography of 1.3 ± 0.9 (scale, 0 to 4).
CONCLUSIONS: Aortic valve repair with pericardial leaflet extension is a promising technique for the growing child.
| Introduction |
|---|
|
|
|---|
Promising early and mid-term results using glutaraldehyde-treated autologous pericardium for leaflet or cusp extension are emerging [2, 3, 9, 10, 1722]. This report reviews our initial experience with glutaraldehyde-preserved autologous pericardial leaflet extension for repairing congenital aortic valve pathology. We also review the outcome of restoring the natural tricuspid configuration of the failing congenitally bicuspid valve.
| Patients and Methods |
|---|
|
|
|---|
|
A number of standard reparative techniques were used in this series featuring autologous pericardial leaflet extensions as the hallmark (see Table 2). The leaflet extensions were sutured to the free edges of the residual native leaflets with a running suture of polypropylene. Native leaflets exhibiting excessive fibrosis, thickening, and restriction were trimmed and thinned out to healthy tissue prior to extension with autologous pericardium. The extensions were also attached to the aortic wall creating neocommissures just below the sinotubular junction. Apposition in the center and adequate coaption surface was assessed and imperfections were corrected. The leaflets were anchored by full-thickness suture bites passing through the aorta wall and tied on the outside over a pericardial buttress (Fig 1). As our experience matured, every attempt was made to convert the congenitally bicuspid valve to a natural trileaflet configuration using autologous pericardial leaflet extensions (Figs 1, 2).
|
|
Combined procedures included tricuspid valve repairs in 8% (5 of 62), mitral valve repairs in 11% (7 of 62), pulmonary valve replacement in 1, and coronary revascularization in 2 older patients (Table 3). The other non-aortic valvular repairs were annuloplasties performed with a strip of glutaraldehyde-treated pericardium.
|
The primary end points of this retrospective study were early and late mortality, freedom from reoperation and late valve function. The study was approved by the Institutional Review Board at the University of California, Los Angeles Medical Center.
| Results |
|---|
|
|
|---|
-year-old boy with critical bicuspid aortic stenosis underwent reversion to a trileaflet valve with pericardial leaflet extensions. He had an unacceptable residual gradient and required additional pericardial augmentation to enlarge the aorta from the level of the annulus to the mid-ascending aorta to reduce leaflet crowding at the sinotubular junction. In another patient myocardial ischemia was reversed by trimming an excessive pericardial leaflet extension.
There was 1 early mortality and no late mortalities. The mortal event occurred in a 2
-year-old boy with critical aortic stenosis and a bicuspid aortic valve. The peak and mean preoperative gradients on echocardiography were 89 and 36 mm Hg, respectively, with left ventricular hypertrophy and a left ventricular ejection fraction of 64%. At the time of operation there was fusion of the left and right cusps. The noncoronary cusp was large and pliable. The thickening of the free edges of both conjoined and noncoronary leaflet were resected and thinned. The rudimentary median raphe was incised out to the annulus creating a trileaflet valve. The noncoronary leaflet was suspended at a higher level with a horizontal mattress suture of 4-0 polypropylene with pericardial pledgets. The left and right coronary cusps were extended 3 to 4 mm with glutaraldehyde-treated autologous pericardium. To reduce potential crowding at the sinotubular junction, another glutaraldehyde-treated pericardial patch was used to enlarge the ascending aorta from the level of the annulus. The patient separated smoothly from cardiopulmonary bypass and the post repair intraoperative transesophageal echocardiography confirmed a competent aortic valve. The patient was extubated on the day of surgery. A postoperative two-dimensional echocardiography and Doppler study demonstrated a tricuspid aortic valve with minimal AR and mild stenosis. The peak and mean aortic gradients were 28 and 15 mm Hg, respectively. On the evening of this patients discharge (postoperative day 4) he aspirated during feeding and suffered a cardiopulmonary arrest. He was resuscitated and placed on extracorporeal membrane oxygenation. He succumbed to severe anoxic brain injury and multiorgan failure. A postmortem examination confirmed intact reconstruction of the aortic valve, diffuse cerebral edema, and multiorgan ischemia.
Reoperations
There were six reoperations for valve-related conditions with a mean of 17 ± 17.2 months (range, 0.1 to 42.5 months). The mechanism was related to infectious endocarditis in 3 adult patients in their 30s with bicuspid native aortic valves prompting replacement in 2 patients with aortic allograft and bioprosthetic valves and re-repair in one. Another patient who had congenital dwarfism and an osteolytic syndrome affecting connective tissue, cartilage, and bone suffered from panvalvular disease. She required mechanical valve replacement 3 years later after accelerated failure of aortic valve repair with pericardial leaflet extensions. She also needed mechanical valve replacement in the mitral, tricuspid, and pulmonary positions. A fifth patient in his late 20s had a prior history of resection of subaortic stenosis. He underwent aortic valve repair for a stenotic bicuspid aortic valve with a pericardial leaflet extension after re-resection of the subaortic area. He separated from cardiopulmonary bypass uneventfully with excellent hemodynamics and good valve performance, although he suffered a fibrillatory arrest during closure. He was put back on cardiopulmonary bypass for resuscitation and subsequently underwent a modified Konno operation with takedown of the repair in favor of an aortic bioprosthesis. The cause of the ventricular fibrillation was likely due to coronary air embolism. A final, sixth patient in his 30s had severe AR develop a few months after aortic valve repair of a bicuspid leaking valve with pericardial leaflet extensions of the right and left coronary formerly conjoined cusps. He underwent aortic valve replacement with a mechanical device after finding a torn noncoronary cusp and right and left coronary cusps with intact pericardial leaflet extensions. In retrospect, we may have erred in not supporting the noncoronary cusp with a leaflet extension.
The 2-year freedom from valve-related reoperation for patients with congenital heart disease was 92% (Fig 3). For pediatric patients
18 years of age this freedom from valve-related reoperation was 100% at 2 years (Fig 4). Aortic valve repair with pericardial leaflet extensions in the pediatric group has a higher freedom from valve-related reoperations than adults after a mean follow-up of 2 years. Complications due to infectious endocarditis played an insignificant role in the pediatric population in contrast with adults.
|
|
There were no instances of valve thrombosis, thromboembolism, neurologic events, or renal failure in this group. A 10-month-old infant with a history of a modified Konno procedure and subaortic resection for subaortic and aortic stenosis, aortic coarctation repair, and residual ventricular septal defect underwent aortic and mitral valve repair, re-resection of the subaortic area, and ventricular septal defect closure at our institution and experienced postoperative heart block requiring permanent pacing. A 56-year-old man undergoing aortic valve repair for a leaky bicuspid valve with dilation of the ascending aorta through a right mini-thoracotomy had a flail chest from costochrondral separation develop.
Restoration of Trileaflet Configuration in Bicuspid Valves
Thirty-nine patients (63%) had congenitally bicuspid valves with a conjoined leaflet, which was usually the product of fusion between the right and left coronary cusps or some other combination. Thirty-four patients (87%) were successfully converted to trileaflet valves with the use of autologous pericardial extensions (Figs 1, 2). The 2-year freedom from reoperation after trileaflet conversion was 90%, whereas those patients with pericardial leaflet extensions of the bicuspid valves had a lower 2-year freedom from reoperation at 70% (Fig 5). This trend was not statistically important (p = 0.29).
|
| Comment |
|---|
|
|
|---|
The appropriate material for aortic cusp extension remains elusive, although fresh autologous pericardium and bovine pericardium were historically limited by short-term durability [1, 4, 9, 10]. Treatment of autologous pericardium with glutaraldehyde seems to improve durability of these repairs, but for how long remains unknown, although anecdotal evidence points to a 6-year to 8-year limit before an increased hazard for degeneration [7]. Al Fagin and colleagues [1] reported on a series of 20 young adults undergoing aortic valve repair for rheumatic pathology with cusp extension using bovine pericardium. They reported significant improvements in signs and symptoms with good relief of stenosis and regurgitation at a mean of 7
months and at the longest follow-up of 23 months. Duran and colleagues [2, 3, 9, 10] demonstrated improved performance with autologous rather than heterologous bovine pericardial material for cusp extension. In 27 and 64 patients undergoing aortic valve reconstruction with bovine and autologous pericardium, respectively, the actuarial survival and freedom from structural deterioration at 8 years were 82 ± 10 % and 76 ± 11 % for bovine and 91 ± 4 % and 97 ± 2 % for autologous pericardium, respectively [9]. In theory, absent antigenicity with autologous pericardium should confer greater resistance to degeneration than heterologous pericardium independent of treatment with a tanning or fixative agent. The parallel experience of increasing device survival with glutaraldehyde tanning of bioprosthetic valves has resulted in similar treatment of fresh autologous pericardial leaflet extensions because fresh autologous pericardium was associated with poorer results due to early thickening and retraction. Glutaraldehyde treatment endows the pericardium with more resistance to retraction and degeneration, and increases the ease of handling while retaining intrinsic tissue pliability. The effects on long-term calcification and on induction of immunologic responses consistent with host versus graft reaction remain unknown [7].
More recent reports of aortic valve repair with pericardial leaflet extensions show evolving promise. Bozbuga and colleagues [22] reported on 46 patients (mean age, 32 years), who were mostly adults with rheumatic disease undergoing pericardial cusp extensions. Actuarial survival was 98 ± 2 % at 8.6 years. However, disturbingly, the reoperation rate was 20% (4.3% per patient-year) due to significant progression of rheumatic disease with dense fibrosis. The mean interval between repair and reoperation was 28 ±18 months (range, 3 to 58 months). Grinda and coworkers [20] studied aortic valve repair in 89 patients with half the mean age (mean age, 16 ± 5 years) also afflicted with rheumatic disease. The actuarial survival at 5 years was 96%, and 92% were free of redo valvular surgery. At 7 years, 90% of patients were free of valve-related complications. These results, in a much younger population with rheumatic aortic valve pathology, suggest better early and mid-term outcomes with glutaraldehyde-treated autologous pericardial leaflet extensions. The finding of improved freedom from reoperation in younger ages is consistent with the present study findings. Rheumatic valvular pathology may negatively impact the durability of this method of aortic valve repair.
Successful aortic valve repair demands an understanding of anatomy and pathology of the aortic root and requires surgical techniques to address pathology at multiple levels. Subaortic stenosis requires resection. A dilated or restricted aortic annulus will require subcommisuroplasty or an anterior or posterior enlargement. Pathology of the semilunar cusps may manifest with thickening, calcification, retraction, or prolapse that requires leaflet thinning and shaving, leaflet extensions with pericardium or leaflet re-suspension. Leaflet perforations are managed with patches of pericardium. Dilated and aneurysmal sinuses, most commonly the noncoronary, may require exclusion with a pericardial patch (neo-sinus). A dilated sinotubular junction or an ascending aorta, or both, may require plication, aortic wrapping, or resection.
Our experience indicates that the best results are obtained when sufficient native aortic tissue including the hinge point of the native leaflet remains prior to leaflet extension. When possible, repair of congenitally bicuspid aortic valves by tricuspid conversion confers better outcomes, although this did not reach statistical significance in this analysis probably due to insufficient sample size.
The study limitations in this non-random and retrospective study involved 62 patients with heterogeneous valvular pathology, although a congenitally bicuspid valve was featured in more than half the cohort. The mechanisms for AR or stenosis, or both, were similarly heterogeneous related to underlying congenital heart pathology, previous surgical interventions, or percutaneous interventions, or a combination thereof. The surgical repair of the aortic valve (more appropriately, the aortic root or apparatus as in mitral valve disease) was varied with the common denominator in all cases (ie, leaflet extensions with glutaraldehyde preserved autologous pericardium of one, two, or three cusps). In most instances we succeeded in converting the bicuspid aortic valve to a trileaflet valve with division along the median raphe and pericardial leaflet extensions. Additional root procedures to address dilated sinuses of valsalva, annulus, and ascending aorta were necessary in many instances. Thus, the relatively small numbers and confounders make subgroup analysis inherently difficult in comparison with other published series.
In conclusion this study demonstrates that aortic valve repair with autologous leaflet extension is safe and effective in the short and intermediate term for patients with congenital aortic pathology. The mortality and morbidity for this operation is very low. This observation complements the body of literature demonstrating similar results in populations with predominant rheumatic valvular disease. The congenitally bicuspid valve is reliably restored to normal trileaflet configuration with pericardial leaflet extensions in most instances. The trend in this study toward improved freedom from reoperation suggests improved durability of this trileaflet configuration over the repaired bicuspid valve. The potential mechanism for this is unknown, but it may relate to reduction in leaflet stress load and improved flow patterns. At the very least this technique in the intermediate run may spare the growing child the potentially significant complications from alternative strategies (pulmonary autograft, prosthetic valve, and allograft) until a much later and mature date. Aortic reparative techniques will continue to evolve in light of favorable intermediate-term outcomes.
| Discussion |
|---|
|
|
|---|
DR ODIM: Thank you, Dr Kanter. Clearly, if you have disease that has destroyed the aortic root and leaflet tissue that is one setting in which it would be very difficult, at least with present techniques, to repair. Bicuspid aortic valve pathology in the much older patient presents this way in the 6th, 7th, and 8th decades of life, where you have extraordinary amounts of annular and leaflet calcification that make reconstruction very difficult.
DR DOMINIQUE METRAS (Marseille, France): That was a very interesting and spectacular presentation. In the same period of time, how many patients did need an aortic valve replacement? Was that a consecutive series of all aortic valve procedures, or in the same time did you have to replace valves in children?
DR ODIM: Thats a good question. This is not a consecutive series of all operations on the aortic valve during this period. There were patients that had aortic valve replacements with mechanical and other types of prosthetic substitutes based on discussion of available options between surgeon and patient, and the final choice of the patient following an informed consent process.
This series is essentially a consecutive series from the senior surgeon in our group who tackled valves of this nature using autologous pericardial leaflet extensions. For the most part, if we felt the valve could be repaired preoperatively, it was successfully repaired, based on assessments of the aortic root subaortic region, and ascending aorta.
DR METRAS: In other words, what percentage of aortic valve surgery in children is done with this technique as opposed to aortic valve replacement?
DR ODIM: I would have to say, without knowing that number exactly, the majority of our children are getting this technique.
DR RANDAS BATISTA (Curitiba, Brazil): Dr. Odim, I congratulate you and your group for these results. I have a similar experience. We presented our experience in 1986. At that time we had 60 patients; now we have 900. I dont extend the cusps. I prefer to change the whole valve, not do only extension. Most of the times I find the edge of the leaflet to be quite thin, for that reason I prefer to place the suture right at the annulus. Thank you.
DR ODIM: Thank you very much. We acknowledge your excellent and pioneering work. We find, in many instances, because the pathology is heterogeneous, it is necessary to resect variable amounts of leaflet tissue. And from time to time, we will go to the annulus and reconstruct from that point.
DR HILLEL LAKS (Los Angeles, CA): I just want to mention two cases that Jonah mentioned. There were two neonates who had truncal valve with both regurgitation and stenosis, which were quite severe; four-leaflet valves that would have required a very complex repair or else root replacement. In both of them, they were converted to three-leaflet valves with leaflet extension after debridement of the thickened leaflets and both had completely competent, unobstructed valves at the end. So this is a tremendous part of the armamentarium of the surgeon in this kind of procedure.
And with regard to the limitations, in children, I would say that pretty much every bicuspid valve is amenable to this kind of repair. As Dr Batista mentioned, there are some children who have a connective tissue weakness with a very dilated root and with very thinned-out leaflets, there was no raphe. So it is a truly bicuspid valve with no thickened raphe. And in those, just dividing and then sewing the leaflet extension, we have also been concerned about the possibility of dehiscence. And in some of those, we did two-leaflet repairs.
One of the failures was a patient, who, as Jonah mentioned, we extended only two leaflets, and at that time we suspended the larger leaflet hoping that if we left at least one leaflet without the replacement it would last even longer. And it turned out that this one leaflet re-prolapsed and caused the regurgitation, so we now feel that if youre going to do the extension all three leaflets should be extended.
And the other point that Jonah made already is that you have to anchor them full thickness with the pledget outside the aorta to avoid them cutting through and prolapsing.
And the other issue is that in children who have a hyperplastic ascending aorta with a three-leaflet extension, you end up with quite a mass of tissue near the sinotubular junction. And in order to avoid a gradient, which we had in 2 patients, and once we got about a 20-mm, 30-mm gradient in each of them, we went back and just put a patch on the ascending aorta and the gradient completely disappeared. So in the small aorta we think that you should, as part of your treatment, make the aorta slightly bigger with a patch at the time of the initial repair.
But the beauty of this is that you have a very low-risk procedure and you can put off a Ross, which damages two valves, until a child is in his teens, instead of doing it when hes 3 or 4. And we think that thats one of the major advantages. It doesnt mean you cant do the Ross in the future if this valve deteriorates at that point.
|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H.-J. Schafers, D. Aicher, S. Riodionycheva, A. Lindinger, T. Radle-Hurst, F. Langer, and H. Abdul-Khaliq Bicuspidization of the unicuspid aortic valve: a new reconstructive approach. Ann. Thorac. Surg., June 1, 2008; 85(6): 2012 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Goetz, T. E. Tan, K. H. Lim, S. L. H. Salgues, N. Grousson, F. Xiong, Y. L. Chua, and J. H. Yeo Truly stentless molded autologous pericardial aortic valve prosthesis with single point attached commissures in a sheep model Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 548 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tao, X. J. Zeng, and Y. P. Lim Single Cusp Replacement for Aortic Regurgitation Ann. Thorac. Surg., March 1, 2008; 85(3): 946 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Bacha, D. B. McElhinney, K. J. Guleserian, S. D. Colan, R. A. Jonas, P. J. del Nido, and G. R. Marx Surgical aortic valvuloplasty in children and adolescents with aortic regurgitation: Acute and intermediate effects on aortic valve function and left ventricular dimensions J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 552 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tao and X.-J. Zeng Replacement of Right Coronary Leaflet With Bovine Pericardium Asian Cardiovasc Thorac Ann, February 1, 2008; 16(1): 47 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. McMullan, G. Oppido, B. Davies, Y. Kawahira, A. D. Cochrane, Y. d'Udekem d'Acoz, D. J. Penny, and C. P. Brizard Surgical strategy for the bicuspid aortic valve: Tricuspidization with cusp extension versus pulmonary autograft J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 90 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dave and R. Pretre Pericardial patch reconstruction of the congenitally diseased aortic valve MMCTS, May 7, 2007; 2007(0507): 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J De La Zerda, O. Cohen, M. C. Fishbein, J. Odim, C. A Calderon, D. Hekmat, I. Dinov, and H. Laks Aortic valve-sparing repair with autologous pericardial leaflet extension has a greater early re-operation rate in congenital versus acquired valve disease Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 256 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aboulhosn and J. S. Child Left Ventricular Outflow Obstruction: Subaortic Stenosis, Bicuspid Aortic Valve, Supravalvar Aortic Stenosis, and Coarctation of the Aorta Circulation, November 28, 2006; 114(22): 2412 - 2422. [Full Text] [PDF] |
||||
![]() |
B. Alsoufi, T. Karamlou, T. Bradley, W. G. Williams, G. S. Van Arsdell, J. G. Coles, J. Smallhorn, M. Nii, V. Guerra, and C. A. Caldarone Short and midterm results of aortic valve cusp extension in the treatment of children with congenital aortic valve disease. Ann. Thorac. Surg., October 1, 2006; 82(4): 1292 - 1300. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |